OnKure Therapeutics Statistics Share Statistics OnKure Therapeutics has 13.51M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 13.51M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 88.98% Shares Floating n/a Failed to Deliver (FTD) Shares 490 FTD / Avg. Volume 0.31%
Short Selling Information The latest short interest is 244.42K, so 1.81% of the outstanding
shares have been sold short.
Short Interest 244.42K Short % of Shares Out 1.81% Short % of Float 2.57% Short Ratio (days to cover) 3.96
Valuation Ratios The PE ratio is -2.18 and the forward
PE ratio is -0.58.
OnKure Therapeutics's PEG ratio is
-0.04.
PE Ratio -2.18 Forward PE -0.58 PS Ratio 0 Forward PS 41.1 PB Ratio 1.1 P/FCF Ratio -2.24 PEG Ratio -0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for OnKure Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.73,
with a Debt / Equity ratio of 0.01.
Current Ratio 10.73 Quick Ratio 10.73 Debt / Equity 0.01 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage -181.29
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.15M Employee Count 46 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -84.85% in the
last 52 weeks. The beta is 0.4, so OnKure Therapeutics's
price volatility has been higher than the market average.
Beta 0.4 52-Week Price Change -84.85% 50-Day Moving Average 2.46 200-Day Moving Average 6.39 Relative Strength Index (RSI) 29.72 Average Volume (20 Days) 156,264
Income Statement
Revenue n/a Gross Profit n/a Operating Income -54.39M Net Income -52.67M EBITDA -51.71M EBIT -52.37M Earnings Per Share (EPS) -3.95
Full Income Statement Balance Sheet The company has 110.76M in cash and 1.08M in
debt, giving a net cash position of 109.68M.
Cash & Cash Equivalents 110.76M Total Debt 1.08M Net Cash 109.68M Retained Earnings -154.72M Total Assets 99.88M Working Capital 89.39M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -51.12M
and capital expenditures -52K, giving a free cash flow of -51.17M.
Operating Cash Flow -51.12M Capital Expenditures -52K Free Cash Flow -51.17M FCF Per Share -3.84
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields OKUR does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for OKUR is $32.5,
which is 1501% higher than the current price. The consensus rating is "Buy".
Price Target $32.5 Price Target Difference 1501% Analyst Consensus Buy Analyst Count 4
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 7, 2024. It was a
backward
split with a ratio of 1:10.
Last Split Date Oct 7, 2024 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -1.75 Piotroski F-Score 2
